Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

CALCCalciMedica, Inc.

Nasdaq · CIK 0001534133
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts269

Identity from submissions API

NameCalciMedica, Inc.
CIK0001534133
TickersCALC
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2834 Pharmaceutical Preparations
EIN452120079
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone858-952-5500
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • CalciMedica, Inc. /DE/ (2023-03-22T00:00:00.000Z → 2023-03-22T00:00:00.000Z)
  • GRAYBUG VISION, INC. (2017-07-18T00:00:00.000Z → 2023-03-15T00:00:00.000Z)
  • GRAYBUG, Inc. (2015-03-06T00:00:00.000Z → 2016-05-13T00:00:00.000Z)
  • GRAYBUG LLC (2011-11-08T00:00:00.000Z → 2014-10-07T00:00:00.000Z)
Business address
505 COAST BOULEVARD SOUTH
SUITE 307
LA JOLLA
CA
92037
CA
Mailing address
505 COAST BOULEVARD SOUTH
SUITE 307
LA JOLLA
CA
92037
CA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

539 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-19 4 xslF345X06/form4-11192026_091133.xml 0002165242-26-000003 5855
2026-11-19 3 xslF345X06/form3-11192026_091114.xml 0002165242-26-000002 23370
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001649553-26-000142 005-91725 261558839 34 12210
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-005216 005-91725 261557927 34 10818
2026-11-16 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-127771 005-91725 261556429 34 17100
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001440771-26-000029 005-91725 261555695 34 18983
2026-11-10 10-Q 10-Q 0001193125-26-455490 001-39538 261540555 34 12679438 1 1
2026-11-10 8-K 8-K 2.02,9.01 0001193125-26-454430 001-39538 261537933 34 466838 1 1
2026-11-05 4 xslF345X06/form4-11052026_041104.xml 0001576244-26-000006 5861
2026-10-16 8-K 8-K 5.02 0001193125-26-424203 001-39538 261466684 34 137065 1 1
2026-10-05 4 xslF345X06/form4-10052026_091008.xml 0001823197-26-000002 5963
2026-10-05 4 xslF345X06/form4-10052026_091046.xml 0001674797-26-000007 5977
2026-10-05 4 xslF345X06/form4-10052026_091056.xml 0001825009-26-000003 5956
2026-10-05 4 xslF345X06/form4-10052026_091056.xml 0001626850-26-000002 5956
2026-10-05 4 xslF345X06/form4-10052026_091035.xml 0001189022-26-000005 5954
2026-09-30 8-K 8-K 8.01,9.01 0001193125-26-409049 001-39538 261427227 34 160330 1 1
2026-09-30 424B5 424B5 0001193125-26-409041 333-293972 261427190 33 418728
2026-09-28 4 xslF345X06/form4-09282026_080927.xml 0001968793-26-000007 5853
2026-09-28 4 xslF345X06/form4-09282026_080937.xml 0001969388-26-000003 5862
2026-09-28 4 xslF345X06/form4-09282026_080935.xml 0001942596-26-000003 5849
2026-09-28 4 xslF345X06/form4-09282026_080938.xml 0001484729-26-000006 5875
2026-09-23 S-8 S-8 0001193125-26-399649 333-299099 261401735 33 201585 1 1
2026-09-16 8-K 8-K 8.01 0001193125-26-393034 001-39538 261383676 34 138617 1 1
2026-09-02 8-K 8-K 8.01 0001193125-26-379419 001-39538 261352704 34 140646 1 1
2026-08-27 8-K 8-K 5.03,9.01 0001193125-26-369713 001-39538 261325525 34 163996 1 1
2026-08-25 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001440771-26-000018 005-91725 261316104 34 19293
2026-08-24 4 FORM 4 0000912282-26-001157 8616
2026-08-24 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0000912282-26-001155 005-91725 261311455 34 184133
2026-08-21 4 xslF345X06/form4-08212026_100848.xml 0001626850-26-000001 5953
2026-08-21 4 xslF345X06/form4-08212026_100824.xml 0001823197-26-000001 5961
2026-08-21 4 xslF345X06/form4-08212026_100850.xml 0001825009-26-000002 5954
2026-08-21 4 xslF345X06/form4-08212026_100845.xml 0001674797-26-000006 13222
2026-08-21 4 xslF345X06/form4-08212026_100838.xml 0001189022-26-000004 11723
2026-08-21 4 xslF345X06/form4-08212026_100852.xml 0001968793-26-000006 9276
2026-08-21 4 xslF345X06/form4-08212026_100837.xml 0001576244-26-000005 9941
2026-08-21 4 xslF345X06/form4-08212026_100832.xml 0001484729-26-000005 9336
2026-08-21 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001193125-26-361273 005-91725 261305593 34 20349
2026-08-20 8-K 8-K 5.02,5.07,9.01 0001193125-26-357258 001-39538 261296769 34 387947 1 1
2026-08-14 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000919574-26-005261 005-91725 261277843 34 9628
2026-08-14 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-003558 005-91725 261277032 34 10707
2026-08-11 10-Q 10-Q 0001193125-26-344689 001-39538 261263415 34 11409323 1 1
2026-08-11 8-K 8-K 2.02,9.01 0001193125-26-343428 001-39538 261260607 34 447866 1 1
2026-07-31 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-002514 333-297681 261230203 33 2040
2026-07-24 S-3 S-3 0001193125-26-316100 333-297681 261201621 33 658808 1 1
2026-07-23 ARS ARS 0001193125-26-314090 001-39538 261197099 34 2735491
2026-07-23 DEF 14A DEF 14A 0001193125-26-314085 001-39538 261197070 34 3794591 1 1
2026-07-20 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001649553-26-000074 005-91725 261187632 34 15740
2026-07-13 PRE 14A PRE 14A 0001193125-26-302112 001-39538 261171881 34 3724957 1 1
2026-07-10 3 FORM 3 0000912282-26-000963 5464
2026-07-10 SCHEDULE 13D xslSCHEDULE_13D_X02/primary_doc.xml 0000912282-26-000961 005-91725 261169552 34 195990
2026-07-07 4 xslF345X06/form4-07072026_090755.xml 0001674797-26-000004 5854
2026-07-07 3 xslF345X06/form3-07072026_080730.xml 0001674797-26-000003 12755
2026-07-07 8-K 8-K 5.02 0001193125-26-297475 001-39538 261159452 34 153846 1 1
2026-07-02 SCHEDULE 13D xslSCHEDULE_13D_X02/primary_doc.xml 0001193125-26-295162 005-91725 261153860 34 140169
2026-06-30 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0000912282-26-000883 005-91725 261141903 34 20479
2026-06-29 4 xslF345X06/form4-06292026_080608.xml 0001267959-26-000003 15078
2026-06-29 4 xslF345X06/form4-06292026_080607.xml 0001968793-26-000004 5410
2026-06-29 4 xslF345X06/form4-06292026_080605.xml 0001189022-26-000002 5386
2026-06-29 4 xslF345X06/form4-06292026_080603.xml 0001576244-26-000004 10391
2026-06-29 4 xslF345X06/form4-06292026_080601.xml 0001484729-26-000004 9611
2026-06-25 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001829126-26-006875 005-91725 261122842 34 21838
2026-06-24 8-K 8-K 1.01,3.02,7.01,8.01,9.01 0001193125-26-281246 001-39538 261116703 34 5249004 1 1
2026-06-24 8-K 8-K 1.01,3.02,9.01 0001193125-26-280223 001-39538 261112962 34 421061 1 1
2026-05-20 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000921895-26-001458 005-91725 261005259 34 7402
2026-05-12 10-Q 10-Q 0001193125-26-219426 001-39538 26968589 34 10252326 1 1
2026-05-12 8-K 8-K 2.02,9.01 0001193125-26-218134 001-39538 26965805 34 399656 1 1
2026-05-08 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001213900-26-053986 005-91725 26959472 34 30813
2026-04-30 10-K/A 10-K/A 0001193125-26-197104 001-39538 26924758 34 1788056 1 1
2026-04-07 4 xslF345X06/form4-04072026_090411.xml 0001942596-26-000002 6175
2026-04-07 4 xslF345X06/form4-04072026_090409.xml 0001968793-26-000002 6179
2026-04-07 4 xslF345X06/form4-04072026_090407.xml 0001576244-26-000002 6178
2026-04-07 4 xslF345X06/form4-04072026_090405.xml 0001968792-26-000002 6173
2026-04-07 4 xslF345X06/form4-04072026_090404.xml 0001969388-26-000002 6188
2026-04-07 4 xslF345X06/form4-04072026_090402.xml 0001484729-26-000002 6203
2026-03-18 8-K 8-K 3.01 0001193125-26-114096 001-39538 26769617 34 142437 1 1
2026-03-11 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-000798 333-293972 26745489 33 2039
2026-03-09 CORRESP filename1.htm 0001193125-26-098556 7111
2026-03-06 UPLOAD filename1.pdf 0000000000-26-002366 333-293972 40352
2026-03-03 S-3 S-3 0001193125-26-088562 333-293972 26715785 33 1154780 1 1
2026-03-03 10-K 10-K 0001193125-26-088147 001-39538 26713953 34 20476808 1 1
2026-03-03 8-K 8-K 2.02,9.01 0001193125-26-086658 001-39538 26711039 34 392226 1 1
2026-02-06 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001193805-26-000113 005-91725 26609199 34 17012
2026-01-28 8-K 8-K 8.01 0001193125-26-027462 001-39538 26573770 34 140495 1 1
2026-01-28 8-K 8-K 7.01,8.01,9.01 0001193125-26-025649 001-39538 26568193 34 170042 1 1
2025-12-01 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0002042077-25-000016 005-91725 251539038 34 6347
2025-11-12 10-Q 10-Q 0001193125-25-277617 001-39538 251472947 34 11742786 1 1
2025-11-12 8-K 8-K 2.02,9.01 0001193125-25-275888 001-39538 251468773 34 492244 1 1
2025-11-07 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001213900-25-107608 005-91725 251462438 34 30278
2025-11-06 8-K 8-K 8.01,9.01 0001193125-25-269526 001-39538 251458379 34 161743 1 1
2025-11-06 424B5 424B5 0001193125-25-269496 333-273949 251458216 33 14976
2025-10-29 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-103689 005-91725 251429593 34 17563
2025-10-14 4 xslF345X05/form4-10142025_041014.xml 0001823197-25-000003 5669
2025-09-22 4 xslF345X05/form4-09222025_090901.xml 0001576244-25-000007 9213
2025-09-17 4 xslF345X05/form4-09172025_090902.xml 0001576244-25-000005 9611
2025-09-15 4 xslF345X05/form4-09152025_040948.xml 0001576244-25-000003 9213
2025-09-11 4 xslF345X05/form4-09112025_120901.xml 0001415889-25-024256 9611
2025-09-09 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001829126-25-007253 005-91725 251303572 34 18782
2025-09-02 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001829126-25-007019 005-91725 251287145 34 16510
2025-09-02 4 xslF345X05/form4-09022025_050918.xml 0001415889-25-023364 11129
2025-08-25 4 xslF345X05/form4-08252025_090801.xml 0001415889-25-022850 9611
2025-08-21 4 xslF345X05/form4-08212025_120804.xml 0001415889-25-022550 13728
2025-08-21 4 xslF345X05/form4-08212025_120801.xml 0001415889-25-022549 5281
2025-08-19 4 xslF345X05/form4-08192025_010801.xml 0001415889-25-022261 9611
2025-08-18 4 xslF345X05/form4-08182025_120801.xml 0001415889-25-022159 7142
2025-08-12 10-Q 10-Q 0000950170-25-107334 001-39538 251206894 34 11385695 1 1
2025-08-12 8-K 8-K 2.02,9.01 0000950170-25-106918 001-39538 251204027 34 492489 1 1
2025-08-05 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-074358 005-91725 251186754 34 9455
2025-07-29 4 xslF345X05/form4-07292025_040701.xml 0001415889-25-020458 7010
2025-07-23 4 xslF345X05/form4-07232025_030740.xml 0001415889-25-020164 9214
2025-07-22 4 xslF345X05/form4-07222025_040709.xml 0001415889-25-020111 9609
2025-07-21 4 xslF345X05/form4-07212025_060739.xml 0001415889-25-020052 8432
2025-07-18 4 xslF345X05/form4-07182025_060737.xml 0001415889-25-019998 4858
2025-07-18 4 xslF345X05/form4-07182025_060757.xml 0001415889-25-019997 9213
2025-07-16 4 xslF345X05/form4-07162025_040730.xml 0001415889-25-019822 9611
2025-07-15 4 xslF345X05/form4-07162025_010710.xml 0001415889-25-019816 8433
2025-07-10 4 xslF345X05/form4-07112025_120755.xml 0001415889-25-019655 9215
2025-07-02 4 xslF345X05/form4-07032025_010721.xml 0001415889-25-019190 5577
2025-06-27 4 xslF345X05/form4-06272025_110619.xml 0001415889-25-018438 9613
2025-06-27 S-8 POS S-8 POS 0001193125-25-151240 333-288287 251086209 33 35729
2025-06-27 8-K 8-K 5.02,5.07,9.01 0001193125-25-151234 001-39538 251086160 34 159902 1 1
2025-06-26 4 xslF345X05/form4-06262025_100630.xml 0001415889-25-018310 6034
2025-06-26 4 xslF345X05/form4-06262025_100618.xml 0001415889-25-018309 9212
2025-06-26 4 xslF345X05/form4-06262025_100610.xml 0001415889-25-018308 6043
2025-06-26 4 xslF345X05/form4-06262025_100613.xml 0001415889-25-018307 6033
2025-06-26 4 xslF345X05/form4-06262025_100621.xml 0001415889-25-018306 6028
2025-06-26 4 xslF345X05/form4-06262025_100619.xml 0001415889-25-018305 6055
2025-06-26 4 xslF345X05/form4-06262025_100609.xml 0001415889-25-018304 13084
2025-06-26 4 xslF345X05/form4-06262025_100646.xml 0001415889-25-018303 13078
2025-06-26 4 xslF345X05/form4-06262025_100625.xml 0001415889-25-018300 13061
2025-06-26 4 xslF345X05/form4-06262025_100600.xml 0001415889-25-018298 13071
2025-06-26 4 xslF345X05/form4-06262025_100629.xml 0001415889-25-018297 13051
2025-06-24 S-8 S-8 0001193125-25-145764 333-288287 251069645 33 231983
2025-06-13 4 xslF345X05/form4-06132025_050601.xml 0001415889-25-017250 9213
2025-06-09 4 xslF345X05/form4-06092025_080603.xml 0001415889-25-016218 11520
2025-06-09 DEFA14A DEFA14A 0001193125-25-137807 001-39538 251034007 34 15679
2025-06-06 8-K 8-K 4.01,9.01 0001193125-25-136297 001-39538 251028857 34 149383 1 1
2025-06-03 4 xslF345X05/form4-06032025_050601.xml 0001415889-25-015421 4860
2025-05-28 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001829126-25-004015 005-91725 25997127 34 40108
2025-05-14 10-Q 10-Q 0000950170-25-071421 001-39538 25945743 34 10465983 1 1
2025-05-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000935836-25-000330 005-91725 25945434 34 19521
2025-05-14 8-K 8-K 2.02,9.01 0000950170-25-070910 001-39538 25942647 34 471104 1 1
2025-04-30 ARS ARS 0001193125-25-104121 001-39538 25889735 34 7465344
2025-04-30 DEFA14A DEFA14A 0001193125-25-104114 001-39538 25889715 34 523364
2025-04-29 DEF 14A DEF 14A 0000950170-25-060362 001-39538 25889667 34 13679075 1 1
2025-04-25 4 xslF345X05/form4-04252025_080459.xml 0001415889-25-011365 5701
2025-04-25 4 xslF345X05/form4-04252025_080402.xml 0001415889-25-011362 5714
2025-04-25 4 xslF345X05/form4-04252025_080404.xml 0001415889-25-011361 5699
2025-04-25 4 xslF345X05/form4-04252025_080421.xml 0001415889-25-011360 5704
2025-04-25 4 xslF345X05/form4-04252025_080420.xml 0001415889-25-011359 5705
2025-04-25 4 xslF345X05/form4-04252025_080419.xml 0001415889-25-011358 5726
2025-04-01 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-030774 005-91725 25801675 34 12592
2025-03-27 10-K 10-K 0000950170-25-046035 001-39538 25779161 34 24112356 1 1
2025-03-27 8-K 8-K 2.02,9.01 0000950170-25-045729 001-39538 25775303 34 437947 1 1
2025-03-05 8-K 8-K 1.01,2.03,3.02,8.01,9.01 0001193125-25-046225 001-39538 25708804 34 652049 1 1
2025-03-04 8-K 8-K 7.01,8.01,9.01 0001193125-25-044830 001-39538 25701501 34 194116 1 1
2025-03-03 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-019840 005-91725 25699198 34 13868
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000950170-25-020607 005-91725 25624834 34 12601
2025-01-16 4 xslF345X05/form4-01172025_120159.xml 0001415889-25-001595 5702
2025-01-16 3 xslF345X02/form3-01172025_120145.xml 0001415889-25-001594 8244
2025-01-14 8-K 8-K 5.02 0001193125-25-005654 001-39538 25527744 34 152050 1 1
2024-12-20 8-K 8-K 8.01,9.01 0001193125-24-283105 001-39538 241567947 34 171067 1 1
2024-12-20 424B5 424B5 0001193125-24-283094 333-273949 241567883 33 467350
2024-12-13 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000935836-24-000758 005-91725 241547990 34 19638
2024-12-06 4 xslF345X05/form4-12072024_121223.xml 0001415889-24-028563 14476
2024-11-26 SC 13D SC 13D 0001193125-24-265556 005-91725 241498000 34 258611
2024-11-15 3 xslF345X02/form3-11152024_091150.xml 0001415889-24-026941 12570
2024-11-14 SC 13G/A AMENDMENT NO. 2 TO SCHEDULE 13G 0001213900-24-098327 005-91725 241461045 34 202544
2024-11-14 SC 13G/A calc13ga1.htm 0000935836-24-000691 005-91725 241459694 34 29128
2024-11-13 SC 13G/A calc13ga1.htm 0000935836-24-000667 005-91725 241455855 34 61244
2024-11-13 10-Q 10-Q 0000950170-24-126296 001-39538 241454052 34 9219892 1 1
2024-11-13 8-K 8-K 2.02,9.01 0000950170-24-125933 001-39538 241451161 34 370651 1 1
2024-11-08 8-K 8-K 5.02 0001193125-24-253754 001-39538 241438141 34 158512 1 1
2024-11-06 4/A xslF345X05/form4a-11062024_081102.xml 0001415889-24-026280 5499
2024-11-06 SC 13D/A SC 13D/A 0001193125-24-252056 005-91725 241431258 34 111644
2024-11-05 4 xslF345X05/form4-11052024_081117.xml 0001415889-24-026103 26065
2024-11-05 4 xslF345X05/form4-11052024_081149.xml 0001415889-24-026102 16056
2024-11-01 4 xslF345X05/form4-11012024_051148.xml 0001415889-24-025880 7726
2024-11-01 4 xslF345X05/form4-11012024_051115.xml 0001415889-24-025878 9221
2024-11-01 4 xslF345X05/form4-11012024_051102.xml 0001415889-24-025876 4866
2024-10-31 8-K 8-K 1.01,8.01,9.01 0001193125-24-248761 001-39538 241415871 34 421643 1 1
2024-10-31 424B5 424B5 0001193125-24-248759 333-273949 241415840 33 625083
2024-10-30 424B5 424B5 0001193125-24-247665 333-273949 241411512 33 626240
2024-10-30 8-K 8-K 2.02,8.01,9.01 0001193125-24-247643 001-39538 241411164 34 180464 1 1
2024-10-30 8-K 8-K 7.01,8.01,9.01 0001193125-24-247004 001-39538 241407448 34 13876735 1 1
2024-09-11 4 xslF345X05/form4-09112024_050902.xml 0001415889-24-023226 8038
2024-08-28 4 xslF345X05/form4-08282024_110854.xml 0001415889-24-022509 5699
2024-08-28 4 xslF345X05/form4-08282024_110809.xml 0001415889-24-022508 5644
2024-08-28 4 xslF345X05/form4-08282024_110830.xml 0001415889-24-022507 5675
2024-08-28 4 xslF345X05/form4-08282024_110840.xml 0001415889-24-022506 5665
2024-08-28 4 xslF345X05/form4-08282024_110857.xml 0001415889-24-022505 5682
2024-08-28 4 xslF345X05/form4-08282024_110824.xml 0001415889-24-022504 5703
2024-08-28 4 xslF345X05/form4-08282024_110845.xml 0001415889-24-022503 5718
2024-08-28 4 xslF345X05/form4-08282024_110858.xml 0001415889-24-022502 5708
2024-08-28 4 xslF345X05/form4-08282024_110856.xml 0001415889-24-022501 5709
2024-08-28 4 xslF345X05/form4-08282024_110856.xml 0001415889-24-022500 5733
2024-08-27 4 xslF345X05/form4-08272024_110843.xml 0001415889-24-022361 8123
2024-08-27 S-8 S-8 0001193125-24-207811 333-281800 241249715 33 71505
2024-08-27 8-K 8-K 5.02,5.07,9.01 0001193125-24-207754 001-39538 241249012 34 366150 1 1
2024-08-26 4 xslF345X05/form4-08262024_090856.xml 0001415889-24-022243 10016
2024-08-26 4 xslF345X05/form4-08262024_090826.xml 0001415889-24-022242 5262
2024-08-22 4 xslF345X05/form4-08222024_100832.xml 0001415889-24-022058 9220
2024-08-12 10-Q 10-Q 0000950170-24-095490 001-39538 241197197 34 8751641 1 1
2024-08-12 8-K 8-K 2.02,9.01 0000950170-24-095450 001-39538 241196977 34 342666 1 1
2024-07-16 ARS ARS 0001193125-24-179349 001-39538 241118611 34 6797189
2024-07-16 DEFA14A DEFA14A 0001193125-24-179346 001-39538 241118602 34 497154
2024-07-16 DEF 14A DEF 14A 0001193125-24-179344 001-39538 241118599 34 1219897
2024-07-08 SC 13G calc13g.htm 0000935836-24-000467 005-91725 241103980 34 30272
2024-07-02 4 xslF345X05/form4-07022024_080711.xml 0001415889-24-018934 5264
2024-07-01 4 xslF345X05/form4-07012024_070708.xml 0001415889-24-018567 5261
2024-06-28 4 xslF345X05/form4-06282024_100627.xml 0001415889-24-018496 9220
2024-06-27 8-K 8-K 7.01,8.01,9.01 0001193125-24-169805 001-39538 241075542 34 5387256 1 1
2024-05-20 4 xslF345X05/form4-05202024_110554.xml 0001415889-24-013834 5803
2024-05-13 10-Q 10-Q 0000950170-24-058744 001-39538 24939819 34 7783673 1 1
2024-05-13 8-K 8-K 2.02,9.01 0000950170-24-058730 001-39538 24939739 34 343305 1 1
2024-04-29 10-K/A 10-K/A 0001193125-24-120151 001-39538 24886693 34 728874 1 1
2024-04-22 4 xslF345X05/form4-04232024_010415.xml 0001415889-24-011354 5701
2024-04-22 4 xslF345X05/form4-04232024_010410.xml 0001415889-24-011353 5646
2024-04-22 4 xslF345X05/form4-04232024_010404.xml 0001415889-24-011352 5677
2024-04-22 4 xslF345X05/form4-04232024_010401.xml 0001415889-24-011351 5667
2024-04-22 4 xslF345X05/form4-04232024_010454.xml 0001415889-24-011350 5684
2024-04-22 4 xslF345X05/form4-04232024_010442.xml 0001415889-24-011349 5705
2024-04-22 4 xslF345X05/form4-04232024_010428.xml 0001415889-24-011348 5720
2024-04-22 4 xslF345X05/form4-04232024_010420.xml 0001415889-24-011346 5710
2024-04-22 4 xslF345X05/form4-04232024_010443.xml 0001415889-24-011344 5711
2024-04-22 4 xslF345X05/form4-04232024_010439.xml 0001415889-24-011343 5735
2024-04-10 8-K 8-K 4.01,9.01 0001193125-24-092036 001-39538 24836561 34 158037 1 1
2024-04-02 4 xslF345X05/form4-04032024_120452.xml 0001415889-24-009884 10754
2024-03-29 8-K 8-K 8.01,9.01 0001193125-24-081584 001-39538 24802126 34 171687 1 1
2024-03-29 424B5 424B5 0001193125-24-081580 333-273949 24802119 33 14344
2024-03-28 S-8 S-8 0001193125-24-080792 333-278336 24799940 33 68179
2024-03-28 10-K 10-K 0000950170-24-038064 001-39538 24799247 34 15546637 1 1
2024-03-28 8-K 8-K 2.02,9.01 0000950170-24-037609 001-39538 24793478 34 391255 1 1
2024-02-13 8-K 8-K 7.01,8.01,9.01 0001193125-24-033981 001-39538 24630261 34 10226591 1 1
2024-02-09 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-02-09 16:00:00 9999999995-24-000374 333-276793 24617186 33 2046
2024-02-08 SC 13D/A SC 13D/A 0001193125-24-028560 005-91725 24610482 34 105111
2024-02-08 SC 13G/A AMENDMENT NO. 1 TO SCHEDULE 13G 0001213900-24-011378 005-91725 24607250 34 168361
2024-02-07 SC 13G/A calc13g020724.htm 0001616824-24-000023 005-91725 24602916 34 79204
2024-02-07 CORRESP filename1.htm 0001193125-24-025896 7563
2024-02-06 4 xslF345X05/form4-02062024_100209.xml 0001415889-24-002832 15450
2024-02-06 UPLOAD filename1.pdf 0000000000-24-001432 333-276793 40605
2024-02-05 SC 13D/A AMENDMENT NO. 4 0000947871-24-000092 005-91725 24596470 34 93788
2024-02-01 SC 13G e619220_sc13g-calcimedica.htm 0001193805-24-000118 005-91725 24588033 34 106476
2024-02-01 SC 13G SCHEDULE 13G 0001213900-24-008994 005-91725 24587103 34 142674
2024-01-31 S-3 S-3 0001193125-24-021064 333-276793 24583899 33 1070982
2024-01-31 SC 13G calc13g.htm 0000935836-24-000078 005-91725 24583314 34 60337
2024-01-26 SC 13G SCHEDULE 13G 0001213900-24-006981 005-91725 24567913 34 110521
2024-01-25 4 xslF345X05/form4-01252024_080106.xml 0001415889-24-001831 51302
2024-01-25 4 xslF345X05/form4-01252024_080106.xml 0001415889-24-001830 57919
2024-01-25 4 xslF345X05/form4-01252024_080101.xml 0001415889-24-001828 13962
2024-01-25 4 xslF345X05/form4-01252024_080102.xml 0001415889-24-001829 10445
2024-01-24 8-K/A 8-K/A 1.01,2.02,3.02,7.01,8.01,9.01 0001193125-24-013513 001-39538 24554170 34 1062633 1 1
2024-01-22 8-K 8-K 1.01,2.02,3.02,7.01,8.01,9.01 0001193125-24-011738 001-39538 24547176 34 1053130 1 1
2023-12-13 4 FORM 4 SUBMISSION 0001209191-23-058568 4781
2023-11-22 SC 13D/A SC 13D/A 0001193125-23-282278 005-91725 231433927 34 139603
2023-11-09 10-Q 10-Q 0000950170-23-062176 001-39538 231393371 34 9689152 1 1
2023-11-09 8-K 8-K 2.02,9.01 0000950170-23-061514 001-39538 231390013 34 423877 1 1
2023-11-08 4 FORM 4 SUBMISSION 0001209191-23-054770 8743
2023-11-08 4 FORM 4 SUBMISSION 0001209191-23-054769 9843
2023-11-07 4 FORM 4 SUBMISSION 0001209191-23-054635 11579
2023-11-07 4 FORM 4 SUBMISSION 0001209191-23-054633 8747
2023-11-07 4 FORM 4 SUBMISSION 0001209191-23-054632 5254
2023-11-06 4 FORM 4 SUBMISSION 0001209191-23-054578 11585
2023-11-06 4 FORM 4 SUBMISSION 0001209191-23-054577 8354
2023-11-02 8-K 8-K 2.02,8.01,9.01 0001193125-23-268948 001-39538 231370412 34 196397 1 1
2023-10-10 4 FORM 4 SUBMISSION 0001209191-23-052521 73511
2023-10-10 3 FORM 3 SUBMISSION 0001209191-23-052515 16969
2023-09-05 4/A FORM 4/A SUBMISSION 0001209191-23-048235 5257
2023-08-29 4 FORM 4 SUBMISSION 0001209191-23-047674 9842
2023-08-23 4 FORM 4 SUBMISSION 0001209191-23-047106 12299
2023-08-18 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2023-08-18 16:00:00 9999999995-23-002449 333-273949 231187157 33 1998
2023-08-16 CORRESP filename1.htm 0001193125-23-214310 7156
2023-08-15 UPLOAD filename1.pdf 0000000000-23-008883 40480
2023-08-11 S-3 S-3 0001193125-23-210902 333-273949 231165105 33 1346753
2023-08-11 8-K 8-K 8.01,9.01 0001193125-23-210794 001-39538 231164518 34 2966441 1 1
2023-08-11 10-Q 10-Q 0000950170-23-041844 001-39538 231164070 34 9288840 1 1
2023-08-10 8-K 8-K 2.02,5.07,9.01 0001193125-23-209160 001-39538 231160509 34 249161 1 1
2023-06-28 4 FORM 4 SUBMISSION 0001209191-23-040098 5608
2023-06-28 4 FORM 4 SUBMISSION 0001209191-23-040097 5597
2023-06-28 4 FORM 4 SUBMISSION 0001209191-23-040096 5606
2023-06-28 4 FORM 4 SUBMISSION 0001209191-23-040095 5575
2023-06-28 ARS ARS 0000950170-23-030404 001-39538 231052435 34 2188349
2023-06-28 DEFA14A DEFA14A 0000950170-23-030398 001-39538 231052286 34 2291639
2023-06-28 DEF 14A DEF 14A 0000950170-23-030390 001-39538 231052205 34 2324530
2023-06-27 8-K 8-K 5.08 0001193125-23-176143 001-39538 231047323 34 150059 1 1
2023-06-26 4 FORM 4 SUBMISSION 0001209191-23-039831 12887
2023-06-22 4 FORM 4 SUBMISSION 0001209191-23-039176 11930
2023-06-15 4/A FORM 4/A SUBMISSION 0001209191-23-037586 5591
2023-06-15 8-K 8-K 7.01,9.01 0001193125-23-167330 001-39538 231015903 34 11253114 1 1
2023-06-13 CERT 8A CERT 0001354457-23-000393 001-39538 231012032 34 118420
2023-06-13 8-A12B 8-A12B 0001193125-23-166014 001-39538 231011247 34 13643
2023-06-12 8-K 8-K 7.01,9.01 0001193125-23-165409 001-39538 231008917 34 174214 1 1
2023-06-09 4 FORM 4 SUBMISSION 0001209191-23-036129 13782
2023-06-09 4 FORM 4 SUBMISSION 0001209191-23-036128 9841
2023-06-09 4 FORM 4 SUBMISSION 0001209191-23-036127 10266
2023-06-08 4 FORM 4 SUBMISSION 0001209191-23-035613 15306
2023-06-08 4 FORM 4 SUBMISSION 0001209191-23-035612 11976
2023-06-08 4 FORM 4 SUBMISSION 0001209191-23-035609 10662
2023-06-05 4 FORM 4 SUBMISSION 0001209191-23-034646 8352
2023-06-05 4/A FORM 4/A SUBMISSION 0001209191-23-034642 5652
2023-06-05 4 FORM 4 SUBMISSION 0001209191-23-034639 12144
2023-06-01 4 FORM 4 SUBMISSION 0001209191-23-033461 8056
2023-06-01 4 FORM 4 SUBMISSION 0001209191-23-033460 7787
2023-06-01 4 FORM 4 SUBMISSION 0001209191-23-033459 9841
2023-05-24 4 FORM 4 SUBMISSION 0001209191-23-032025 4746
2023-05-24 4 FORM 4 SUBMISSION 0001209191-23-032024 8060
2023-05-24 4 FORM 4 SUBMISSION 0001209191-23-032023 11186
2023-05-23 SC 13D/A e618664_sc13da-calcimedica.htm 0001193805-23-000782 005-91725 23949931 34 170127
2023-05-22 4 FORM 4 SUBMISSION 0001209191-23-031472 6264
2023-05-22 4 FORM 4 SUBMISSION 0001209191-23-031382 13783
2023-05-18 4 FORM 4 SUBMISSION 0001209191-23-030782 11222
2023-05-18 4 FORM 4 SUBMISSION 0001209191-23-030780 5252
2023-05-18 4 FORM 4 SUBMISSION 0001209191-23-030779 12352
2023-05-18 4 FORM 4 SUBMISSION 0001209191-23-030778 7667
2023-05-15 8-K 8-K 2.02,9.01 0001193125-23-144226 001-39538 23918567 34 225261 1 1
2023-05-12 S-8 S-8 0001193125-23-143616 333-271898 23916931 33 106724
2023-05-12 10-Q 10-Q 0000950170-23-021775 001-39538 23915885 34 9109920 1 1
2023-05-12 8-K/A 8-K/A 9.01 0001193125-23-143469 001-39538 23915690 34 795809 1 1
2023-05-12 8-K 8-K 4.02 0001193125-23-143456 001-39538 23915482 34 154963 1 1
2023-05-10 4 FORM 4 SUBMISSION 0001209191-23-028552 5679
2023-05-10 4 FORM 4 SUBMISSION 0001209191-23-028551 5678
2023-05-10 4 FORM 4 SUBMISSION 0001209191-23-028550 5672
2023-05-10 4 FORM 4 SUBMISSION 0001209191-23-028547 5687
2023-05-10 4 FORM 4 SUBMISSION 0001209191-23-028546 5704
2023-05-05 8-K 8-K 3.01,8.01 0001193125-23-137097 001-39538 23893882 34 156528 1 1
2023-05-03 4 FORM 4 SUBMISSION 0001209191-23-027199 9304
2023-05-03 3 FORM 3 SUBMISSION 0001209191-23-027198 7554
2023-05-03 4 FORM 4 SUBMISSION 0001209191-23-027196 17525
2023-05-03 3 FORM 3 SUBMISSION 0001209191-23-027193 6570
2023-04-14 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2023-04-14 16:00:00 9999999995-23-000946 333-271115 23822712 33 1997
2023-04-12 CORRESP filename1.htm 0001193125-23-099209 7141
2023-04-10 UPLOAD filename1.pdf 0000000000-23-003564 40535
2023-04-04 S-3 S-3 0001193125-23-090982 333-271115 23798815 33 384773
2023-04-04 8-K/A 8-K/A 9.01 0001193125-23-090853 001-39538 23797418 34 757227 1 1
2023-04-04 10-K/A 10-K/A 0001193125-23-090842 001-39538 23797238 34 649668 1 1
2023-04-04 D xslFormDX01/primary_doc.xml 06b 0001921043-23-000002 021-477891 23796742 33 15342
2023-03-30 SC 13D SC 13D 0001193125-23-085803 005-91725 23781978 34 143594
2023-03-30 SC 13G SC 13G 0001193125-23-085503 005-91725 23780558 34 119272
2023-03-28 SC 13D/A e618407_sc13da-calcimedica.htm 0001193805-23-000396 005-91725 23766552 34 133027
2023-03-27 4 FORM 4 SUBMISSION 0001209191-23-021307 9963
2023-03-27 4 FORM 4 SUBMISSION 0001209191-23-021306 8121
2023-03-27 4 FORM 4 SUBMISSION 0001209191-23-021305 8099
2023-03-27 4 FORM 4 SUBMISSION 0001209191-23-021303 9777
2023-03-27 4 FORM 4 SUBMISSION 0001209191-23-021301 8124
2023-03-27 4 FORM 4 SUBMISSION 0001209191-23-021300 9642
2023-03-27 4 FORM 4 SUBMISSION 0001209191-23-021298 8060
2023-03-27 4 FORM 4 SUBMISSION 0001209191-23-021297 8107
2023-03-27 SC 13D/A e618404_sc13da-calcimedica.htm 0001193805-23-000392 005-91725 23764641 34 151699
2023-03-24 SC 13D/A AMENDMENT NO. 3 0000947871-23-000381 005-91725 23760575 34 91492
2023-03-22 4 FORM 4 SUBMISSION 0001209191-23-020684 67212
2023-03-22 4 FORM 4 SUBMISSION 0001209191-23-020683 9317
2023-03-22 4 FORM 4 SUBMISSION 0001209191-23-020682 22805
2023-03-22 4 FORM 4 SUBMISSION 0001209191-23-020680 49234
2023-03-22 4 FORM 4 SUBMISSION 0001209191-23-020679 35174
2023-03-22 4 FORM 4 SUBMISSION 0001209191-23-020678 43458
2023-03-22 4 FORM 4 SUBMISSION 0001209191-23-020677 31263
2023-03-22 4 FORM 4 SUBMISSION 0001209191-23-020676 44655
2023-03-22 3 FORM 3 SUBMISSION 0001209191-23-020672 6197
2023-03-22 3 FORM 3 SUBMISSION 0001209191-23-020671 6198
2023-03-22 3 FORM 3 SUBMISSION 0001209191-23-020670 6205
2023-03-22 3 FORM 3 SUBMISSION 0001209191-23-020668 6281
2023-03-22 3 FORM 3 SUBMISSION 0001209191-23-020666 6295
2023-03-22 3 FORM 3 SUBMISSION 0001209191-23-020665 6281
2023-03-22 3 FORM 3 SUBMISSION 0001209191-23-020664 6261
2023-03-22 3 FORM 3 SUBMISSION 0001209191-23-020663 6278
2023-03-22 8-K 8-K 2.01,3.01,3.02,3.03,5.01,5.02,5.03,8.01,9.01 0001193125-23-076714 001-39538 23753149 34 2990376 1 1
2023-03-15 8-K 8-K 5.07,8.01 0001193125-23-071452 001-39538 23736052 34 172536 1 1
2023-03-15 4 FORM 4 SUBMISSION 0001209191-23-018885 9102
2023-03-09 10-K 10-K 0000950170-23-006795 001-39538 23717934 34 11999777 1 1
2023-03-06 4 FORM 4 SUBMISSION 0001209191-23-016514 14027
2023-03-06 4 FORM 4 SUBMISSION 0001209191-23-016513 14001
2023-03-06 4 FORM 4 SUBMISSION 0001209191-23-016509 13988
2023-03-03 DEFA14A DEFA14A 0001193125-23-060023 001-39538 23703954 34 74626
2023-03-03 8-K 8-K 5.02,8.01 0001193125-23-059999 001-39538 23703768 34 235551 1 1
2023-02-16 DEFA14A DEFA14A 0001193125-23-041106 001-39538 23638852 34 92497
2023-02-16 8-K 8-K 1.01,9.01 0001193125-23-041092 001-39538 23638816 34 246090 1 1
2023-02-13 SC 13G/A SC 13G/A 0001104659-23-019065 005-91725 23614839 34 391833
2023-02-10 UPLOAD filename1.pdf 0000000000-23-001410 39989
2023-02-09 DEFM14A DEFM14A 0001193125-23-030343 001-39538 23607311 34 14700969
2023-02-09 8-K 8-K 5.02,9.01 0001193125-23-030003 001-39538 23606220 34 189613 1 1
2023-02-08 SC 13G/A NONE 0001567619-23-002102 005-91725 23599993 34 66959
2023-02-06 CORRESP filename1.htm 0001193125-23-024831 25344
2023-02-06 PRER14A PRER14A 0001193125-23-024800 001-39538 23588285 34 10775082
2023-02-03 UPLOAD filename1.pdf 0000000000-23-001151 45346
2023-01-31 CORRESP filename1.htm 0001193125-23-020420 45126
2023-01-31 PRER14A PRER14A 0001193125-23-020415 001-39538 23573063 34 10742402
2023-01-27 UPLOAD filename1.pdf 0000000000-23-000929 52035
2023-01-20 CORRESP filename1.htm 0001193125-23-012047 60871
2023-01-20 PRER14A PRER14A 0001193125-23-012044 001-39538 23541348 34 10719777
2023-01-11 UPLOAD filename1.pdf 0000000000-23-000296 63985
2022-12-28 8-K 8-K 3.01 0001193125-22-313722 001-39538 221494433 34 149618 1 1
2022-12-14 PREM14A PREM14A 0001193125-22-304920 001-39538 221462992 34 10698738
2022-12-14 4 FORM 4 SUBMISSION 0001209191-22-061177 9034
2022-12-01 4 FORM 4 SUBMISSION 0001209191-22-059207 9060
2022-12-01 4 FORM 4 SUBMISSION 0001209191-22-059206 9099
2022-12-01 4 FORM 4 SUBMISSION 0001209191-22-059205 9075
2022-12-01 SC 13G NONE 0001567619-22-021110 005-91725 221438723 34 66971
2022-11-29 4 FORM 4 SUBMISSION 0001209191-22-058951 9045
2022-11-29 4 FORM 4 SUBMISSION 0001209191-22-058950 9123
2022-11-29 4 FORM 4 SUBMISSION 0001209191-22-058949 9092
2022-11-23 SC 13D/A e618056_sc13da-graybug.htm 0001193805-22-001604 005-91725 221415844 34 159167

Latest XBRL company facts

One latest value per concept from companyfacts (269 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 6.90M 2026-11-05 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
dei EntityPublicFloat Entity Public Float USD 15.70M 2025-06-30 2025 FY 10-K/A 2026-04-30 0001193125-26-197104
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 1.67M 2025-01-01 2025-12-31 DEF 14A 2026-07-23 0001193125-26-314085
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 733,437 2025-01-01 2025-12-31 DEF 14A 2026-07-23 0001193125-26-314085
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD 2.44M 2025-01-01 2025-12-31 DEF 14A 2026-07-23 0001193125-26-314085
ecd PeoTotalCompAmt PeoTotalCompAmt USD 895,410 2025-01-01 2025-12-31 DEF 14A 2026-07-23 0001193125-26-314085
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 230 2025-01-01 2025-12-31 DEF 14A 2026-07-23 0001193125-26-314085
ffd NetFeeAmt NetFeeAmt USD 444.52 2026-09-22 S-8 2026-09-23 0001193125-26-399649
ffd TtlFeeAmt TtlFeeAmt USD 444.52 2026-09-22 S-8 2026-09-23 0001193125-26-399649
ffd TtlOfferingAmt TtlOfferingAmt USD 3.22M 2026-09-22 S-8 2026-09-23 0001193125-26-399649
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-09-22 S-8 2026-09-23 0001193125-26-399649
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-07-21 S-3 2026-07-24 0001193125-26-316100
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 1.02M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap AccountsPayableRelatedPartiesCurrent Accounts Payable, Related Parties, Current USD 0 2020-12-31 2020 FY 10-K 2021-03-05 0001564590-21-011305
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 61,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 200,000 2022-12-31 2022 FY 10-K 2023-03-09 0000950170-23-006795
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 685,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap AccruedRentCurrent Accrued Rent, Current USD 13,300 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 1.65M 2021-12-31 2022 FY 10-K 2023-03-09 0000950170-23-006795
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -7,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 197.91M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 496,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 216,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-27 0000950170-25-046035
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 12.04M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-28 0000950170-24-038064
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 10.61M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 1.60M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-09 0000950170-23-006795
us-gaap Assets Assets USD 14.29M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap AssetsCurrent Assets, Current USD 14.22M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure USD 34.20M 2022-12-31 2022 FY 10-K 2023-03-09 0000950170-23-006795
us-gaap AssetsHeldForSaleNotPartOfDisposalGroup Assets Held-for-sale, Not Part of Disposal Group USD 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap AssetsHeldForSaleNotPartOfDisposalGroupCurrent Assets Held-for-sale, Not Part of Disposal Group, Current USD 350,000 2022-09-30 2022 Q3 10-Q 2022-11-10 0001564590-22-037397
us-gaap BusinessCombinationAcquisitionRelatedCosts Business Combination, Acquisition Related Costs USD 10.50M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-27 0000950170-25-046035
us-gaap BusinessCombinationConsiderationTransferred1 Business Combination, Consideration Transferred USD 29.40M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets USD 2.10M 2024-12-31 2024 FY 10-K 2025-03-27 0000950170-25-046035
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable USD 2.30M 2024-12-31 2024 FY 10-K 2025-03-27 0000950170-25-046035
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 115,000 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-09 0000950170-23-006795
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 4.57M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap CashAndCashEquivalentsFairValueDisclosure Cash and Cash Equivalents, Fair Value Disclosure USD 12.37M 2022-12-31 2022 FY 10-K 2023-03-09 0000950170-23-006795
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 13.80M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 4.57M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -6.95M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 0 2022-12-31 2023 FY 10-K 2024-03-28 0000950170-24-038064
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 8.36M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 11.08M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 100.00M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 6.89M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 6.89M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap CommonStockValue Common Stock, Value, Issued USD 1,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -4.36M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap ContractualObligation Contractual Obligation USD 9.10M 2022-12-31 2022 FY 10-K 2023-03-09 0000950170-23-006795
us-gaap ConversionOfStockAmountIssued1 Conversion of Stock, Amount Issued USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-27 0000950170-25-046035
us-gaap ConvertibleNotesPayable Convertible Notes Payable USD 0 2023-12-31 2023 FY 10-K 2024-03-28 0000950170-24-038064
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months USD 33.50M 2022-09-30 2022 Q3 10-Q 2022-11-10 0001564590-22-037397
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss USD 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 11,000 2025-12-31 2025 FY 10-K 2026-03-03 0001193125-26-088147
us-gaap DeferredRentCreditCurrent Deferred Rent Credit, Current USD 8,000 2021-12-31 2022 FY 10-K 2023-03-09 0000950170-23-006795
us-gaap DeferredRentCreditNoncurrent Deferred Rent Credit, Noncurrent USD 8,000 2021-12-31 2022 FY 10-K 2023-03-09 0000950170-23-006795
us-gaap DeferredTaxAssetsGoodwillAndIntangibleAssets Deferred Tax Assets, Goodwill and Intangible Assets USD 10.54M 2025-12-31 2025 FY 10-K 2026-03-03 0001193125-26-088147
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 92.66M 2025-12-31 2025 FY 10-K 2026-03-03 0001193125-26-088147
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 0 2025-12-31 2025 FY 10-K 2026-03-03 0001193125-26-088147
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 66.33M 2025-12-31 2025 FY 10-K 2026-03-03 0001193125-26-088147
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsDomestic Deferred Tax Assets, Operating Loss Carryforwards, Domestic USD 315.40M 2025-12-31 2025 FY 10-K 2026-03-03 0001193125-26-088147
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal Deferred Tax Assets, Operating Loss Carryforwards, State and Local USD 0 2024-12-31 2024 FY 10-K 2025-03-27 0000950170-25-046035
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 1.70M 2023-12-31 2023 FY 10-K 2024-03-28 0000950170-24-038064
us-gaap DeferredTaxAssetsStateTaxes Deferred Tax Assets, State Taxes USD 9.87M 2023-12-31 2023 FY 10-K 2024-03-28 0000950170-24-038064
us-gaap DeferredTaxAssetsTaxCreditCarryforwards Deferred Tax Assets, Tax Credit Carryforwards USD 14.33M 2025-12-31 2025 FY 10-K 2026-03-03 0001193125-26-088147
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 12.40M 2023-12-31 2023 FY 10-K 2024-03-28 0000950170-24-038064
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 1.39M 2025-12-31 2025 FY 10-K 2026-03-03 0001193125-26-088147
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals USD 93,000 2023-12-31 2023 FY 10-K 2024-03-28 0000950170-24-038064
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 92.65M 2025-12-31 2025 FY 10-K 2026-03-03 0001193125-26-088147
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 11,000 2025-12-31 2025 FY 10-K 2026-03-03 0001193125-26-088147
us-gaap DefinedContributionPlanEmployerDiscretionaryContributionAmount Defined Contribution Plan, Employer Discretionary Contribution Amount USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap DepositsAssetsNoncurrent Deposits Assets, Noncurrent USD 608,000 2020-12-31 2020 FY 10-K 2021-03-05 0001564590-21-011305
us-gaap Depreciation Depreciation USD 21,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 58,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-28 0000950170-24-038064
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.96 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.48 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-12 0001564590-22-019611
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.96 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-09 0000950170-23-006795
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.149 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-09 0000950170-23-006795
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure -0.053 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-09 0000950170-23-006795
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure -0.025 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-09 0000950170-23-006795
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure 0.017 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-09 0000950170-23-006795
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 758,000 2023-03-31 2023 Q1 10-Q 2023-05-12 0000950170-23-021775
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 11.50M 2022-12-31 2022 FY 10-K 2023-03-09 0000950170-23-006795
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD -7.70M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap FairValueAssetsLevel1ToLevel2TransfersAmount Fair Value, Assets, Level 1 to Level 2 Transfers, Amount USD 0 2022-03-31 2022 Q1 10-Q 2022-05-12 0001564590-22-019611
us-gaap FairValueAssetsLevel2ToLevel1TransfersAmount Fair Value, Assets, Level 2 to Level 1 Transfers, Amount USD 0 2022-03-31 2022 Q1 10-Q 2022-05-12 0001564590-22-019611
us-gaap FairValueLiabilitiesLevel1ToLevel2TransfersAmount Fair Value, Liabilities, Level 1 to Level 2 Transfers, Amount USD 0 2022-03-31 2022 Q1 10-Q 2022-05-12 0001564590-22-019611
us-gaap FairValueLiabilitiesLevel2ToLevel1TransfersAmount Fair Value, Liabilities, Level 2 to Level 1 Transfers, Amount USD 0 2022-03-31 2022 Q1 10-Q 2022-05-12 0001564590-22-019611
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers Into Level 3 USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-09 0000950170-23-006795
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3 USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-09 0000950170-23-006795
us-gaap FairValueNetAssetLiability Fair Value, Net Asset (Liability) USD 300,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap GainLossOnDispositionOfAssets1 Gain (Loss) on Disposition of Assets USD -97,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-09 0000950170-23-006795
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD 31,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 6.47M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 0 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-13 0000950170-24-126296
us-gaap ImpairmentOfLongLivedAssetsToBeDisposedOf Impairment of Long-Lived Assets to be Disposed of USD 1.31M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-09 0000950170-23-006795
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001193125-26-088147
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -29.56M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001193125-26-088147
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD -29.56M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001193125-26-088147
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001193125-26-088147
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 5.47M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-03 0001193125-26-088147
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -2.88M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-03 0001193125-26-088147
us-gaap IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Amount USD 705,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-28 0000950170-24-038064
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 611,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-03 0001193125-26-088147
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD -1.05M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-03 0001193125-26-088147
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD -441,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD -104,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-09 0000950170-23-006795
us-gaap IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities USD 410,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap IncreaseDecreaseInDeferredCharges Increase (Decrease) in Deferred Charges USD -1,000 2021-01-01 2021-09-30 2022 Q3 10-Q 2022-11-10 0001564590-22-037397
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -380,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-09 0000950170-23-006795
us-gaap IncreaseDecreaseInOtherCurrentLiabilities Increase (Decrease) in Other Current Liabilities USD -747,000 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-12 0001564590-20-053539
us-gaap IncreaseDecreaseInOtherOperatingLiabilities Increase (Decrease) in Other Operating Liabilities USD -1.89M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-09 0000950170-23-006795
us-gaap IncrementalCommonSharesAttributableToShareBasedPaymentArrangements Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements shares 479,284 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-12 0001193125-26-219426
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 1.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 1.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 575,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-09 0000950170-23-006795
us-gaap IssuanceOfStockAndWarrantsForServicesOrClaims Issuance of Stock and Warrants for Services or Claims USD 8,000 2022-01-01 2022-09-30 2023 Q3 10-Q 2023-11-09 0000950170-23-062176
us-gaap LeaseAndRentalExpense Operating Leases, Rent Expense USD 30,000 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-13 0000950170-24-058744
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 118,000 2023-03-31 2023 Q1 10-Q 2023-05-12 0000950170-23-021775
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 70,000 2025-12-31 2025 FY 10-K 2026-03-03 0001193125-26-088147
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 103,000 2022-09-30 2022 Q3 10-Q 2022-11-10 0001564590-22-037397
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 1,000 2023-03-31 2023 Q1 10-Q 2023-05-12 0000950170-23-021775
us-gaap Liabilities Liabilities USD 10.07M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 14.29M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap LiabilitiesCurrent Liabilities, Current USD 2.87M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap LiabilitiesFairValueDisclosure Financial and Nonfinancial Liabilities, Fair Value Disclosure USD 0 2023-12-31 2024 FY 10-K 2025-03-27 0000950170-25-046035
us-gaap LineOfCreditFacilityMaximumBorrowingCapacity Line of Credit Facility, Maximum Borrowing Capacity USD 10.00M 2026-06-23 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap LongTermInvestments Long-term Investments USD 4.63M 2021-06-30 2021 Q2 10-Q 2021-08-12 0001564590-21-044001
us-gaap LossContingencyDamagesSoughtValue Loss Contingency, Damages Sought, Value USD 1.50M 2025-04-11 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 13.99M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -7.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -13.34M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -4.35M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -4.35M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap NetRentableArea Net Rentable Area sqft 691 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1 Noncash or Part Noncash Acquisition, Fixed Assets Acquired USD 334,000 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-14 0000950170-25-071421
us-gaap NoninterestIncome Noninterest Income USD 294,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 10.02M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap OperatingExpenses Operating Expenses USD 14.37M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -14.37M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 500,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-09 0000950170-23-006795
us-gaap OperatingLeaseImpairmentLoss Operating Lease, Impairment Loss USD 290,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-09 0000950170-23-006795
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 117,000 2023-03-31 2023 Q1 10-Q 2023-05-12 0000950170-23-021775
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 203,000 2022-12-31 2022 FY 10-K 2023-03-09 0000950170-23-006795
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 102,000 2022-03-31 2022 Q1 10-Q 2022-05-12 0001564590-22-019611
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 0 2023-12-31 2023 FY 10-K 2024-03-28 0000950170-24-038064
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 277,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-09 0000950170-23-006795
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 732,000 2021-12-31 2022 FY 10-K 2023-03-09 0000950170-23-006795
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 118,000 2023-03-31 2023 Q1 10-Q 2023-05-12 0000950170-23-021775
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 205,000 2020-12-31 2020 FY 10-K 2021-03-05 0001564590-21-011305
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 205,000 2021-12-31 2022 FY 10-K 2023-03-09 0000950170-23-006795
us-gaap OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear Operating Leases, Future Minimum Payments, Remainder of Fiscal Year USD 146,000 2021-09-30 2021 Q3 10-Q 2021-11-12 0001564590-21-056418
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 1.62M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap OtherAssets Other Assets USD 4,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap OtherAssetsCurrent Other Assets, Current USD 1.35M 2021-12-31 2022 FY 10-K 2023-03-09 0000950170-23-006795
us-gaap OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent USD -7,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax USD -6,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 0 2023-12-31 2023 FY 10-K 2024-03-28 0000950170-24-038064
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 231,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap OtherRestructuringCosts Other Restructuring Costs USD 299,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-09 0000950170-23-006795
us-gaap OtherSundryLiabilitiesCurrent Other Sundry Liabilities, Current USD 77,000 2022-12-31 2022 FY 10-K 2023-03-09 0000950170-23-006795
us-gaap OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale, Recognized in Earnings USD 0 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-13 0000950170-24-058744
us-gaap PaymentsOfMergerRelatedCostsFinancingActivities Payments of Merger Related Costs, Financing Activities USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-27 0000950170-25-046035
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap PaymentsRelatedToTaxWithholdingForShareBasedCompensation Payment, Tax Withholding, Share-based Payment Arrangement USD 139,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-09 0000950170-23-006795
us-gaap PaymentsToAcquireInProcessResearchAndDevelopment Payments to Acquire in Process Research and Development USD 1.94M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-09 0000950170-23-006795
us-gaap PaymentsToAcquireInvestments Payments to Acquire Investments USD 9.14M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap PaymentsToAcquireShortTermInvestments Payments to Acquire Short-term Investments USD 21.52M 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-14 0001564590-21-028030
us-gaap PreferredStockDividendsIncomeStatementImpact Preferred Stock Dividends, Income Statement Impact USD 7.19M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-11 0001564590-22-009728
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 432,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap PrepaidExpenseAndOtherAssetsNoncurrent Prepaid Expense and Other Assets, Noncurrent USD 29,000 2021-12-31 2022 FY 10-K 2023-03-09 0000950170-23-006795
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 503,000 2022-12-31 2022 FY 10-K 2023-03-09 0000950170-23-006795
us-gaap ProceedsFromConvertibleDebt Proceeds from Convertible Debt USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 10.20M 2024-11-01 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 11.17M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap ProceedsFromIssuanceOfConvertiblePreferredStock Proceeds from Issuance of Convertible Preferred Stock USD 54.78M 2019-01-01 2019-12-31 2020 FY 10-K 2021-03-05 0001564590-21-011305
us-gaap ProceedsFromIssuanceOfWarrants Proceeds from Issuance of Warrants USD 2.79M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap ProceedsFromOtherEquity Proceeds from Other Equity USD 31,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments Proceeds from Sale, Maturity and Collection of Short-term Investments USD 8.00M 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-14 0001564590-21-028030
us-gaap ProceedsFromSaleMaturityAndCollectionsOfInvestments Proceeds from Sale, Maturity and Collection of Investments USD 1.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 42,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -4.35M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 3.63M 2021-12-31 2022 FY 10-K 2023-03-09 0000950170-23-006795
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 72,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 7.91M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap ResearchAndDevelopmentInProcess Research and Development in Process USD 2.19M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-09 0000950170-23-006795
us-gaap RestrictedCash Restricted Cash USD 0 2023-12-31 2023 FY 10-K 2024-03-28 0000950170-24-038064
us-gaap RestructuringAndRelatedCostNumberOfPositionsEliminated Restructuring and Related Cost, Number of Positions Eliminated Employee 20 2022-09-01 2022-10-31 2022 FY 10-K 2023-03-09 0000950170-23-006795
us-gaap RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent Restructuring and Related Cost, Number of Positions Eliminated, Period Percent pure 0.71 2022-08-18 2022 FY 10-K 2023-03-09 0000950170-23-006795
us-gaap RestructuringCharges Restructuring Charges USD 3.00M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-09 0000950170-23-006795
us-gaap RestructuringSettlementAndImpairmentProvisions Restructuring, Settlement and Impairment Provisions USD 2.96M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-09 0000950170-23-006795
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -193.68M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 567,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-09 0000950170-23-006795
us-gaap SeveranceCosts1 Severance Costs USD 5.70M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-27 0000950170-25-046035
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 1.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost Share-based Payment Arrangement, Accelerated Cost USD 128.00M 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-05 0001564590-21-011305
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber Share-based Compensation Arrangement by Share-based Payment Award, Accelerated Vesting, Number shares 61,812 2019-01-01 2019-12-31 2020 FY 10-K 2021-03-05 0001564590-21-011305
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1 Share-based Payment Arrangement, Expensed and Capitalized, Amount USD 1.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 0 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-12 0001193125-26-219426
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number shares 4,500 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 1.21 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum pure 0.88 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-09 0000950170-23-006795
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum pure 0.87 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-09 0000950170-23-006795
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.043 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum pure 0.029 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-09 0000950170-23-006795
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum pure 0.016 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-09 0000950170-23-006795
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 41.97M 2021-12-31 2021 FY 10-K 2022-03-11 0001564590-22-009728
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 2.40M 2022-12-31 2022 FY 10-K 2023-03-09 0000950170-23-006795
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 5.87 2022-12-31 2022 FY 10-K 2023-03-09 0000950170-23-006795
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-09 0000950170-23-006795
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 56,237 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 1.35M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 0.96 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-09 0000950170-23-006795
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 15.94M 2025-12-31 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 2.26M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Period Increase (Decrease), Weighted Average Exercise Price USD/shares 76.72 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-28 0000950170-24-038064
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 9.16 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value USD 14,000 2026-06-30 2026 Q2 10-Q 2026-08-11 0001193125-26-344689
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number shares 682,312 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price USD/shares 21.75 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value USD 4.00M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-11 0001564590-22-009728
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value USD/shares 6.06 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-11 0001564590-22-009728
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 10.28 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 1.89 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate Share-based Goods and Nonemployee Services Transaction, Valuation Method, Expected Dividend Rate pure 0 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-13 0000950170-24-058744
us-gaap ShortTermInvestments Short-term Investments USD 9.19M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 4.23M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap StockIssuedDuringPeriodSharesAcquisitions Stock Issued During Period, Shares, Acquisitions shares 310,431 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-28 0000950170-24-038064
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 62.07M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-27 0000950170-25-046035
us-gaap StockIssuedDuringPeriodValueIssuedForServices Stock Issued During Period, Value, Issued for Services USD 8,000 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-28 0000950170-24-038064
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 31,000 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 25,000 2025-07-01 2025-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap SupplementalUnemploymentBenefitsSeveranceBenefits Supplemental Unemployment Benefits, Severance Benefits USD 3.75M 2023-03-31 2023 Q1 10-Q 2023-05-12 0000950170-23-021775
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 131.36M 2019-12-31 2021 FY 10-K 2022-03-11 0001564590-22-009728
us-gaap TemporaryEquityDividendsAdjustment Temporary Equity, Dividends, Adjustment USD 7.19M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-11 0001564590-22-009728
us-gaap TemporaryEquityLiquidationPreference Temporary Equity, Liquidation Preference USD 148.59M 2019-12-31 2021 FY 10-K 2022-03-11 0001564590-22-009728
us-gaap TemporaryEquitySharesAuthorized Temporary Equity, Shares Authorized shares 142.15M 2019-12-31 2021 FY 10-K 2022-03-11 0001564590-22-009728
us-gaap TemporaryEquitySharesOutstanding Temporary Equity, Shares Outstanding shares 0 2020-09-29 2021 FY 10-K 2022-03-11 0001564590-22-009728
us-gaap UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic Undistributed Earnings (Loss) Allocated to Participating Securities, Basic USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-28 0000950170-24-038064
us-gaap UnrealizedGainLossOnInvestments Unrealized Gain (Loss) on Investments USD 1,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001193125-26-088147
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 5.17M 2025-12-31 2025 FY 10-K 2026-03-03 0001193125-26-088147
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions USD 9.56M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001193125-26-088147
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued USD 0 2025-12-31 2025 FY 10-K 2026-03-03 0001193125-26-088147
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition Unrecognized Tax Benefits, Increase Resulting from Acquisition USD 847,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-27 0000950170-25-046035
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 345,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001193125-26-088147
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions USD 2.91M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001193125-26-088147
us-gaap VariableInterestEntityOwnershipPercentage Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage pure 0.05 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap VariableLeaseCost Variable Lease, Cost USD 500,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-09 0000950170-23-006795
us-gaap WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount1 WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount1 USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-27 0000950170-25-046035
us-gaap WarrantsAndRightsOutstanding Warrants and Rights Outstanding USD 796,000 2023-06-30 2023 Q2 10-Q 2023-08-11 0000950170-23-041844
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 4.51M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 21.36M 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-12 0001564590-22-019611
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 4.51M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455490

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →